MilliporeSigma receives the industry

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Prestigious Journal of Hematology & Oncology Accepts HanchorBio’s Novel CD47-SIRPα Therapeutic, HCB101, for Publication

Prestigious Journal of Hematology & Oncology Accepts HanchorBio’s Novel CD47-SIRPα Therapeutic, HCB101, for Publication

By HanchorBio Inc.
HanchorBio Inc.
23 Oct 2025

Mexico’s First Pharmaceutical Company, IFA Celtics, Deploys ForgeStop

Mexico’s First Pharmaceutical Company, IFA Celtics, Deploys ForgeStop's NFC Anti-Counterfeit Tech

By ForgeStop Technology Corp
ForgeStop Technology Corp
23 Oct 2025

Alcami to expand lab services at Durham, NC facility to meet rising biologics demand

Alcami to expand lab services at Durham, NC facility to meet rising biologics demand

By Alcami
Alcami
22 Oct 2025

ADARx doses first patient in Phase 3 STOP-HAE trial; ADX-324 receives orphan drug designation for hereditary angioedema

ADARx doses first patient in Phase 3 STOP-HAE trial; ADX-324 receives orphan drug designation for hereditary angioedema

By ADARx Pharmaceuticals
ADARx Pharmaceuticals
22 Oct 2025

To drive global expansion of digital chemistry and discovery, Chemify raises over $50 million in an oversubscribed Series B round

To drive global expansion of digital chemistry and discovery, Chemify raises over $50 million in an oversubscribed Series B round

By Chemify
Chemify
21 Oct 2025

Successfully deployed in Myanmar conflict zone, the SurgiField system enables life-saving surgery

Successfully deployed in Myanmar conflict zone, the SurgiField system enables life-saving surgery

By SurgiBox Inc
SurgiBox Inc
16 Oct 2025

Drug Discovery 2024

The Digital Pharma Advances Conference 2026

Most Popular

Avenacy Unveils the Launch of Dehydrated Alcohol Injection, USP Vials in the U.S. Market

By Avenacy

Jul 21
Theralogix Introduces Berberine Enhanced Absorption

By Theralogix

Apr 01
Nuvation Bio’s IBTROZI™ (taletrectinib), a next-generation oral treatment for advanced ROS1-positive non-small cell lung cancer, has been approved by the U.S. Food and Drug Administration

By Nuvation Bio

Jun 12

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

User Area

Discover

Engage with Us